Results 271 to 280 of about 26,872 (292)

QT interval prolongation and the risk of torsades de pointes: essentials for clinicians

Current Medical Research and Opinion, 2013
, Robert Lee Page, James E Tisdale
exaly  

QT prolongation through hERG K+ channel blockade: Current knowledge and strategies for the early prediction during drug development

Medicinal Research Reviews, 2005
Maurizio Recanatini, Elisabetta Poluzzi, Matteo Masetti   +2 more
exaly  

A Comparison of the Risk of QT Prolongation Among SSRIs

Annals of Pharmacotherapy, 2013
Kylee A Funk, Jolene R Bostwick
exaly  

Risk factors for QTc-prolongation: systematic review of the evidence

International Journal of Clinical Pharmacy, 2016
Eline Vandael, , Joris Vandenberghe
exaly  

QT interval prolongation

2017
openaire   +1 more source

Takotsubo cardiomyopathy and QT interval prolongation: who are the patients at risk for torsades de pointes?

Journal of Electrocardiology, 2009
Dan Justo
exaly  

Prolonged QT interval

2014
openaire   +1 more source

Management of QT prolongation induced by anti-cancer drugs: Target therapy and old agents. Different algorithms for different drugs

Cancer Treatment Reviews, 2018
Carmela Coppola, Giovanna Piscopo, Antonio Barbieri   +2 more
exaly  

Prevalence and Outcome of High-Risk QT Prolongation Recorded in the Emergency Department from an Institution-Wide QT Alert System

Journal of Emergency Medicine, 2018
Heather N Anderson, J Martijn Bos, Kristina H Haugaa   +2 more
exaly  

QTc interval prolongation for patients in methadone maintenance treatment: a five years follow-up study

American Journal of Drug and Alcohol Abuse, 2013
Ayman Fareed, Sreedevi Vayalapalli, Jennifer Casarella   +2 more
exaly